Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neuroinflammation ; 9: 37, 2012 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-22356764

RESUMEN

BACKGROUND: In invertebrates, the medicinal leech is considered to be an interesting and appropriate model to study neuroimmune mechanisms. Indeed, this non-vertebrate animal can restore normal function of its central nervous system (CNS) after injury. Microglia accumulation at the damage site has been shown to be required for axon sprouting and for efficient regeneration. We characterized HmC1q as a novel chemotactic factor for leech microglial cell recruitment. In mammals, a C1q-binding protein (C1qBP alias gC1qR), which interacts with the globular head of C1q, has been reported to participate in C1q-mediated chemotaxis of blood immune cells. In this study, we evaluated the chemotactic activities of a recombinant form of HmC1q and its interaction with a newly characterized leech C1qBP that acts as its potential ligand. METHODS: Recombinant HmC1q (rHmC1q) was produced in the yeast Pichia pastoris. Chemotaxis assays were performed to investigate rHmC1q-dependent microglia migration. The involvement of a C1qBP-related molecule in this chemotaxis mechanism was assessed by flow cytometry and with affinity purification experiments. The cellular localization of C1qBP mRNA and protein in leech was investigated using immunohistochemistry and in situ hybridization techniques. RESULTS: rHmC1q-stimulated microglia migrate in a dose-dependent manner. This rHmC1q-induced chemotaxis was reduced when cells were preincubated with either anti-HmC1q or anti-human C1qBP antibodies. A C1qBP-related molecule was characterized in leech microglia. CONCLUSIONS: A previous study showed that recruitment of microglia is observed after HmC1q release at the cut end of axons. Here, we demonstrate that rHmC1q-dependent chemotaxis might be driven via a HmC1q-binding protein located on the microglial cell surface. Taken together, these results highlight the importance of the interaction between C1q and C1qBP in microglial activation leading to nerve repair in the medicinal leech.


Asunto(s)
Proteínas Portadoras/metabolismo , Quimiotaxis/fisiología , Complemento C1q/metabolismo , Hirudo medicinalis/citología , Microglía/fisiología , Sistema Nervioso/citología , Secuencia de Aminoácidos , Animales , Biotinilación , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/genética , Quimiotaxis/efectos de los fármacos , Complemento C1q/genética , Complemento C1q/farmacología , Secuencia Conservada , Electroporación , Citometría de Flujo , Ganglios de Invertebrados/citología , Humanos , Microglía/efectos de los fármacos , ARN Mensajero/metabolismo , Proteínas Recombinantes/metabolismo , Alineación de Secuencia , Factores de Tiempo , Traumatismos del Sistema Nervioso/metabolismo , Traumatismos del Sistema Nervioso/patología
2.
Glia ; 58(14): 1649-62, 2010 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-20578037

RESUMEN

In contrast to mammals, the medicinal leech Hirudo medicinalis can completely repair its central nervous system (CNS) after injury. This invertebrate model offers unique opportunities to study the molecular and cellular basis of the CNS repair processes. When the leech CNS is injured, microglial cells migrate and accumulate at the site of lesion, a phenomenon known to be essential for the usual sprouting of injured axons. In the present study, we demonstrate that a new molecule, designated HmIL-16, having functional homologies with human interleukin-16 (IL-16), has chemotactic activity on leech microglial cells as observed using a gradient of human IL-16. Preincubation of microglial cells either with an anti-human IL-16 antibody or with anti-HmIL-16 antibody significantly reduced microglia migration induced by leech-conditioned medium. Functional homology was demonstrated further by the ability of HmIL-16 to promote human CD4+ T cell migration which was inhibited by antibody against human IL-16, an IL-16 antagonist peptide or soluble CD4. Immunohistochemistry of leech CNS indicates that HmIL-16 protein present in the neurons is rapidly transported and stored along the axonal processes to promote the recruitment of microglial cells to the injured axons. To our knowledge, this is the first identification of a functional interleukin-16 homologue in invertebrate CNS. The ability of HmIL-16 to recruit microglial cells to sites of CNS injury suggests a role for HmIL-16 in the crosstalk between neurons and microglia in the leech CNS repair.


Asunto(s)
Movimiento Celular/fisiología , Ganglios de Invertebrados/citología , Ganglios de Invertebrados/lesiones , Hirudo medicinalis/citología , Hirudo medicinalis/fisiología , Interleucina-16/fisiología , Microglía/fisiología , Homología de Secuencia de Aminoácido , Animales , Células Cultivadas , Modelos Animales de Enfermedad , Ganglios de Invertebrados/fisiología , Humanos , Interleucina-16/antagonistas & inhibidores , Microglía/citología
3.
Mol Immunol ; 46(4): 523-31, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18952286

RESUMEN

In vertebrates, central nervous system (CNS) protection is dependent on many immune cells including microglial cells. Indeed, activated microglial cells are involved in neuroinflammation mechanisms by interacting with numerous immune factors. Unlike vertebrates, some lophotrochozoan invertebrates can fully repair their CNS following injury. In the medicinal leech Hirudo medicinalis, the recruitment of microglial cells at the lesion site is essential for sprouting of injured axons. Interestingly, a new molecule homologous to vertebrate C1q was characterized in leech, named HmC1q (for H. medicinalis) and detected in neurons and glial cells. In chemotaxis assays, leech microglial cells were demonstrated to respond to human C1q. The chemotactic activity was reduced when microglia was preincubated with signaling pathway inhibitors (Pertussis Toxin or wortmannin) or anti-human gC1qR antibody suggesting the involvement of gC1qR in C1q-mediated migration in leech. Assays using cells preincubated with NO chelator (cPTIO) showed that C1q-mediated migration was associated to NO production. Of interest, by using anti-HmC1q antibodies, HmC1q released in the culture medium was shown to exhibit a similar chemotactic effect on microglial cells as human C1q. In summary, we have identified, for the first time, a molecule homologous to mammalian C1q in leech CNS. Its chemoattractant activity on microglia highlights a new investigation field leading to better understand leech CNS repair mechanisms.


Asunto(s)
Sistema Nervioso Central/inmunología , Factores Quimiotácticos/metabolismo , Complemento C1q/metabolismo , Hirudo medicinalis/inmunología , Neuroglía/metabolismo , Neuronas/metabolismo , Secuencia de Aminoácidos , Androstadienos/farmacología , Animales , Anticuerpos Monoclonales/farmacología , Secuencia de Bases , Proteínas Portadoras/efectos de los fármacos , Proteínas Portadoras/inmunología , Proteínas Portadoras/metabolismo , Sistema Nervioso Central/citología , Sistema Nervioso Central/metabolismo , Factores Quimiotácticos/inmunología , Quimiotaxis/fisiología , Complemento C1q/efectos de los fármacos , Complemento C1q/inmunología , Medios de Cultivo Condicionados/metabolismo , Ganglios de Invertebrados/efectos de los fármacos , Ganglios de Invertebrados/inmunología , Ganglios de Invertebrados/metabolismo , Hirudo medicinalis/metabolismo , Humanos , Inmunosupresores/farmacología , Microglía/efectos de los fármacos , Microglía/inmunología , Microglía/metabolismo , Proteínas Mitocondriales/efectos de los fármacos , Proteínas Mitocondriales/inmunología , Proteínas Mitocondriales/metabolismo , Datos de Secuencia Molecular , Neuroglía/efectos de los fármacos , Neuroglía/inmunología , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/inmunología , Óxido Nítrico/inmunología , Óxido Nítrico/metabolismo , Toxina del Pertussis/farmacología , Alineación de Secuencia , Wortmanina
4.
Eur Cytokine Netw ; 20(3): 95-100, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19825517

RESUMEN

The complement system is well known as an enzyme cascade that helps to defend against infections. Indeed, this ancestral system bridges innate and adaptive immunity. Its implication in diseases of the central nervous system (CNS), has led to an increased number of studies. Complement activation in the CNS has been generally considered to contribute to tissue damage. However, recent studies suggest that complement may be neuroprotective, and can participate in maintenance and repair of the adult brain. Here, we will review this dual role of complement proteins and some of their functional interactions with part of the chemokine and cytokine network associated with the protection of CNS integrity.


Asunto(s)
Sistema Nervioso Central/inmunología , Sistema Nervioso Central/patología , Proteínas del Sistema Complemento/inmunología , Inflamación/inmunología , Animales , Humanos , Inflamación/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA